Innovation Capabilities & Products

Authors: Antonio Figueras Huerta, María Gasset Vega, Beatriz Novoa García, Magalí Rey Campos, Ricardo Mallavía Marín, Regla María Medina Gali, Alicia Martínez López

The present invention relates to peptides derived from myticin C and to their therapeutic use, more specifically in cell and/or tissue regeneration. More detailed information can be obtained here.

Authors: Antonio Pineda Lucena; Carla María Vidaurre Agut; Eva María Rivero Buceta; Jose María Benlloch Baviera; Cristian Smerdou Picazo; Beatriz Novoa; Antonio Figueras Huertas; Pablo Botella Asunción

Andrographolid derivatives for their use in the treatment of COVID-19 and associated pulmonary fibrosis. Patent pending publication.

Authors: Eva María Rivero Buceta; Cristian Smerdou Picazo; Pablo Botella Asunción; Antonio Pineda Lucena; Carla María Vidaurre Agut; Beatriz Novoa; Antonio Figueras Huertas;  Jose María Benlloch Baviera

Andrographolide derivatives for their use in the treatment of cytokine-related inflammatory diseases . Patent pending publication.

Authors: María del Mar Costa Portela, Beatriz Novoa García, Antonio Figueras Huerta, Sonia Dios Vidal, Camino Gestal Mateo

The invention provides a method for the identification of polynucleotides, coding precursors of polypeptides, with antibacterial and antiviral activity (myticines and mytilines). More detailed information can be obtained here.

Characterization and measurement of micro-physiological responses or molecular markers generated in response to environmental conditions for the development of an early warning system for environmental perturbations.

Monitoring temporal and spatial distribution of species, abundance and biomass from several taxa using different techniques such as e-DNA, pigment characterization, flow cytometry, acoustic telemetry, images collected from remote observation systems (i.e. drones, etc.) or classic taxonomic identification.  

Studies on the structure of the genome of marine organisms, including gene mapping, DNA sequencing and how the complete set of RNA transcripts is produced by the genome and affected by development, diseases, or environmental factors conditioning the phenotype and particularly proteomics and metabolomics, always applying the most advanced techniques (ATAC-seq, MethylCap-Seq, RNA-seq, recombinant DNA technology, knockin and knockout CRISPR/Cas9, enhancer detector (ZED),Tol2 kit and BAC transgenic technologies, etc.).

Development of techniques (metabolomics, proteomics, genomics, lipidomics, biomarkers) to characterize the response of cells to different biomolecules and to validate their activity and safety.

Pathogen detection and identification in wild and farmed animals, as well as in seafood products. Evaluation of the relationship between pathogen incidence and various environmental and physiological aspects to provide risk assessments for target pathogens.

Development of space-specific tools for assessment, management and decision-making by modeling the impacts of present and possible future environmental scenarios (pollution, climate change, etc.) on oceanographic conditions, biodiversity distribution, physiological response or fisheries and aquaculture performance.